Journal of Surgical Education
Volume 66, Issue 5 , Pages 267-275 , September 2009

Sentinel Lymph Node Biopsy in Breast Cancer: A Comprehensive Literature Review

  • Ahmed Salem, MD

      Affiliations

    • Corresponding Author InformationCorrespondence: Inquiries to Ahmed Salem, MD, Department of Surgery, Al-Bayader Hospital, 8th Circle, Ahman 11814, Jordan; fax: +962 6 585 73 23

References 

  1. Townsend CM, Beauchamp RD, Evers BM, Mattox KL. Sabiston Textbook of Surgery (The Biological Basics of Modern Surgical Practice). 16th ed.. Philadelphia, PA: W. B. Saunders; 2001;
  2. Dixon JM. Sentinel node biopsy. ed. In:  Galimberti V,  Gennari R,  Zerwes F editor. Breast Cancer: Diagnosis and Management. New York: Elsevier Science; 2000;
  3. Feig BW, Berger DH, Fuhrman GM. The M. D. Anderson Surgical Oncology Handbook. 3rd edition. Baltimore, Maryland: Lippincott, Williams, and Wilkins; 2004;
  4. Rovera F, Frattini F, Marelli M, et al. Axillary sentinel node biopsy: an overview. Int J Surg. 2008;(suppl 1):S109–S112
  5. Chen AY, Halpern MT, Schrag NM, et al. Disparities and trends in sentinel node biopsy among early-stage breast cancer patients (1998-2005). J Natl Cancer Inst. 2008;100:462–474
  6. Cody HS. Clinical aspects of sentinel node biopsy. Breast Cancer Res. 2001;3:104–108
  7. Stell VH, Flippo-Morton TS, Norton HJ, et al. Effect of intraoperative radiocolloid injection on sentinel lymph node biopsy in patients with breast cancer. Ann Surg Oncol. 2009;16:2300–2304
  8. McMasters KM, Wong SL, Martin RC, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg. 2001;233:676–687
  9. Koukouraki S, Sanidas E, Askoxilakis J, et al. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?. Nucl Med Commun. 2008;30:48–53
  10. Pan WR, Rozen WM, Stella DL, et al. A three-dimensional analysis of the lymphatics of a bilateral breast specimen: a human cadaveric study. Clin Breast Cancer. 2009;9:86–91
  11. Fowler JC, Solanki CK, Ballinger JR, et al. Axillary lymph node drainage pathways from intradermal and intraparenchymal breast planes. J Surg Res. 2009;Epub ahead of print.
  12. Thompson M, Korourian S, Henry-Tillman R, et al. Intraoperative radioisotope injection for sentinel lymph node biopsy. Ann Surg Oncol. 2008;15:3216–3221
  13. Bleicher RJ, O'Sullivan MJ, Ciocca V, et al. A prospective feasibility trial to determine the significance of the sentinel node gradient in breast cancer: a predictor of nodal metastasis location. Cancer. 2008;113:3100–3107
  14. Mathelin C, Salvador S, Bekaert V, et al. A new intraoperative gamma camera for the sentinel lymph node procedure in breast cancer. Anticancer Res. 2008;28:2859–2864
  15. Gui GP, Joubert DJ, Reichert R, et al. Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer. Eur J Surg Oncol. 2005;31:707–714
  16. van der Ploeg IM, Nieweg OE, Kroon BB, et al. The yield of SPECT/CT for anatomical lymphatic mapping in patients with breast cancer. Eur J Nucl Med Mol Imaging. 2009;36:903–909
  17. Gauthier T, Mollard J, Fermeaux V, et al. Axillary recurrence after negative sentinel lymph node biopsy under local anesthesia in breast cancer. Eur J Surg Oncol. 2008;35:464–468
  18. Teknos D, Ramcharan A, Oluwole SF. Pulmonary edema associated with methylene blue dye administration during sentinel lymph node biopsy. J Natl Med Assoc. 2008;100:1483–1484
  19. Liang MI, Carson WE. Biphasic anaphylactic reaction to blue dye during sentinel lymph node biopsy. World J Surg Oncol. 2008;6:79
  20. Lanitis S, Filippakis G, Sidhu V, et al. Atypical anaphylactic reaction to patent blue during sentinel lymph node biopsy for breast cancer. Ann R Coll Surg Engl. 2008;90:338–339
  21. Kaufman G, Guth AA, Pachter HL, et al. A cautionary tale: anaphylaxis to isosulfan blue dye after 12 years and 3339 cases of lymphatic mapping. Am Surg. 2008;74:152–155
  22. East JM, Valentine CS, Kanchev E, et al. Sentinel lymph node biopsy for breast cancer using methylene blue dye manifests a short learning curve among experienced surgeons: a prospective tabular cumulative sum (CUSUM) analysis. BMC Surg. 2009;9:2
  23. Davis KG, Schriver JP. Prevalence of teaching sentinel lymph node biopsy for breast cancer in general surgery residency programs. Curr Surg. 2002;59:420–422
  24. Teilum D, Kroman N, Friis E. (Sentinel node technique in local relapse after breast-conserving surgery). Ugeskr Laeger. 2008;170:3136–3137
  25. Ruano R, Ramos M, Garcia-Talavera JR, et al. Staging the axilla with selective sentinel node biopsy in patients with previous excision of non-palpable and palpable breast cancer. Eur J Nucl Med Mol Imaging. 2008;35:1299–1304
  26. Karam A, Stempel M, Cody HS, et al. Reoperative sentinel lymph node biopsy after previous mastectomy. J Am Coll Surg. 2008;207:543–548
  27. Palit G, Jacquemyn Y, Tjalma W. Sentinel node biopsy for ipsilateral breast cancer recurrence: A review. Eur J Gynaecol Oncol. 2008;29:565–567
  28. Tausch C, Konstantiniuk P, Kugler F, et al. Austrian Sentinel Node Study Group Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian Sentinel Node Study Group. Ann Surg Oncol. 2008;15:3378–3383
  29. Xing Y, Foy M, Cox DD, et al. Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg. 2006;93:539–546
  30. Hino M, Sano M, Sato N, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy in a patient with operable breast cancer. Surg Today. 2008;38:585–591
  31. Hidar S, Bibi M, Gharbi O, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer. Int J Surg. 2009;7:272–275
  32. Dupont EL, Kuhn MA, McCann C, et al. The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy. Am J Surg. 2000;180:274–277
  33. Boughey JC, Cormier JN, Xing Y, et al. Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy. Cancer. 2007;110:2542–2550
  34. McLaughlin SA, Stempel M, Morris EA, et al. Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?. Cancer. 2008;112:1214–1221
  35. Soran A, Falk J, Bonaventura M, et al. Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? (Magee-Womens Hospital experience). Ann Surg Oncol. 2007;14:646–651
  36. Papa MZ, Zippel D, Kaufman B, et al. Timing of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy for breast cancer. J Surg Oncol. 2008;98:403–406
  37. Menard JP, Extra JM, Jacquemier J, et al. Sentinel lymphadenectomy for the staging of clinical axillary node-negative breast cancer before neoadjuvant chemotherapy. Eur J Surg Oncol. 2009;35(9):916–920
  38. Iwase H, Yamamoto Y, Kawasoe T, et al. Advantage of sentinel lymph node biopsy before neoadjuvant chemotherapy in breast cancer treatment. Surg Today. 2009;39:374–380
  39. Porembka MR, Abraham RL, Sefko JA, et al. Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 seer data. Ann Surg Oncol. 2008;15:2709–2719
  40. Polom K, Murawa D, Wasiewicz J, et al. The role of sentinel node biopsy in ductal carcinoma in situ of the breast. Eur J Surg Oncol. 2009;35:43–47
  41. Takács T, Paszt A, Szentpáli K, et al. Importance of sentinel lymph node biopsy in surgical therapy of in situ breast cancer. Pathol Oncol Res. 2008;Epub ahead of print.
  42. van la Parra RF, Ernst MF, Barneveld PC, et al. The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast. Eur J Surg Oncol. 2008;34:631–635
  43. Jatoi I. Internal mammary sentinel nodes in primary breast cancer. Curr Med Res Opin. 2003;19:567–569
  44. Coombs NJ, Boyages J, French JR, et al. Internal mammary sentinel nodes: ignore, irradiate or operate?. Eur J Cancer. 2008;45:789–794
  45. Schwartz SI, Shires GT, Spencer FC, et al. Principles of Surgery. 7th ed.. New York: McGraw-Hill Health Professions Division; 1999;vol 1.
  46. Rovera F, Frattini F, Marelli M, et al. Axillary sentinel lymph node biopsy: an overview. Int J Surg. 2008;6(suppl 1):S109–S112
  47. Hong J, Choy E, Soni N, et al. Extra-axillary sentinel node biopsy in the management of early breast cancer. Eur J Surg Oncol. 2005;31:942–948
  48. Feng J, Bernacki EG. Intraoperative cytologic evaluation of sentinel lymph nodes in patients with breast carcinoma by scrape preparation. Diagn Cytopathol. 2008;36:790–793
  49. van de Vrande S, Meijer J, Rijnders A, et al. The value of intraoperative frozen section examination of sentinel lymph nodes in breast cancer. Eur J Surg Oncol. 2009;35:276–280
  50. Piato JR, Pincerato KM, Gomes VC, et al. (Occult metastasis in sentinel lymph node in early-stage breast cancer). Rev Bras Ginecol Obstet. 2008;30:432–436
  51. Adams SU. Ortho-Clinical diagnostics. http://www.orthoclinical.com/en-us/Pages/Home.aspx
  52. Julian TB, Blumencranz P, Deck K, et al. Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer. J Clin Oncol. 2008;26:3338–3345
  53. Perhavec A, Besić N, Hocevar M, et al. Touch imprint cytology of the sentinel lymph nodes might not be indicated in early breast cancer patients with ultrasonically uninvolved axillary lymph nodes. Ann Surg Oncol. 2008;15:2257–2262
  54. Gawlick U, Mone MC, Hansen HJ, et al. Selective use of intraoperative sentinel lymph node pathological evaluation in breast cancer. Am J Surg. 2008;196:851–855; discussion, 855-856.
  55. Gill G The SNAC Trial Group of the Royal Australasian College of Surgeons (RACS) and NHMRC Clinical Trials Centre. Sentinel-lymph-node-based management or routine axillary clearance? (One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): A Randomized controlled surgical trial). Ann Surg Oncol. 2009;16:266–275
  56. Lo YF, Hsueh S, Ma SY, Chen SC, et al. Radioguided sentinel lymph node biopsy in early breast cancer: experience at Chang Gung Memorial Hospital. Chang Gung Med J. 2006;29:458–467
  57. Holwitt DM, Gillanders WE, Aft RL, et al. Sentinel lymph node biopsy in patients with multicentric/multifocal breast cancer: Low false-negative rate and lack of axillary recurrence. Am J Surg. 2008;196:562–565
  58. Schwartz GF, Krill LS, Palazzo JP, et al. Value of intraoperative examination of axillary sentinel nodes in carcinoma of the breast. J Am Coll Surg. 2008;207:758–762
  59. Lynch MA, Jackson J, Kim JA, et al. Optimal number of radioactive sentinel lymph nodes to remove for accurate axillary staging of breast cancer. Surgery. 2008;144:525–531; discussion, 531-532.
  60. van Deurzen CH, Borgstein PJ, van Diest PJ. In-transit lymph node metastases in breast cancer: A possible source of local recurrence after sentinel node procedure. J Clin Pathol. 2008;61:1314–1316
  61. Unal B, Gur AS, Kayiran O, et al. Models for predicting non-sentinel lymph node positivity in sentinel node positive breast cancer: the importance of scoring system. Int J Clin Pract. 2008;62:1785–1791
  62. Pugliese MS, Beatty JD, Tickman RJ, et al. Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories. Ann Surg Oncol. 2009;16:113–120
  63. Goyal A, Mansel RE. Recent advances in sentinel lymph node biopsy for breast cancer. Curr Opin Oncol. 2008;20:621–626
  64. Christiansen P, Friis E, Balslev E, et al. Sentinel node biopsy in breast cancer: Five years experience from Denmark. Acta Oncol. 2008;47:561–568
  65. van Deurzen CH, de Boer M, Monninkhof EM, et al. Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. J Natl Cancer Inst. 2008;100:1574–1580
  66. van der Heiden-van der Loo M, Bezemer PD, Hennipman A, et al. Introduction of sentinel node biopsy and stage migration of breast cancer. Eur J Surg Oncol. 2006;32:710–714
  67. Del Bianco P, Zavagno G, Burelli P, et al. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: Results of the Sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol. 2008;34:508–513
  68. McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: Objective measurements. J Clin Oncol. 2008;26:5213–5219
  69. Bulte CS, van der Heiden-van der Loo M, Hennipman A. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study. Eur J Surg Oncol. 2009;35:25–31
  70. Poletti P, Fenaroli P, Milesi A, et al. Axillary recurrence in sentinel lymph node-negative breast cancer patients. Ann Oncol. 2008;19:1842–1846
  71. Veronesi U, Galimberti V, Paganelli G, et al. Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases. Eur J Cancer. 2009;45:1381–1388
  72. van Wely BJ, Smidt ML, de Kievit IM, et al. False-negative sentinel lymph node biopsy. Br J Surg. 2008;95:1352–1355
  73. Bergkvist L, de Boniface J, Jönsson PE, et al. Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish multicenter cohort study. Ann Surg. 2008;247:150–156
  74. Blanco I, Moriyón C, Santamaría L, et al. (Our experience of the clinical application of sentinel node biopsy in breast cancer). Cir Esp. 2007;82:352–357
  75. Zavagno G, Carcoforo P, Franchini Z, et al. Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection: a study on 479 breast cancer patients. Eur J Surg Oncol. 2005;31:715–720
  76. Vanderveen KA, Schneider PD, Khatri VP, et al. Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging. Ann Surg Oncol. 2006;13:1450–1456
  77. Langer I, Guller U, Hsu-Schmitz SF, et al. Sentinel lymph node biopsy is associated with improved survival compared to level I and II axillary lymph node dissection in node negative breast cancer patients. Eur J Surg Oncol. 2009;35:805–813

PII: S1931-7204(09)00121-4

doi: 10.1016/j.jsurg.2009.07.011

Journal of Surgical Education
Volume 66, Issue 5 , Pages 267-275 , September 2009

Article Tools